tm logo
PAPILLON BIOSCIENCES
Live/Pending
NOTICE OF ALLOWANCE - ISSUED

issued

on 19 Dec 2023

Last Applicant/ Owned by

225 South Lake Avenue

Pasadena

CA

91101

Serial Number

97600809 filed on 21st Sep 2022

Registration Number

N/A

Correspondent Address

Bobby A. Ghajar

COOLEY LLP

1299 PENNSYLVANIA AVE NW, SUITE 700

WASHINGTON,DC 20004

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

"BIOSCIENCES"

PAPILLON BIOSCIENCES

Development of nanotechnology-based pharmaceutical preparations for cancer delivery platforms; research and development of pharmaceuticals for the treatment of cancer; research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines "BIOSCIENCES" Pharmaceutical and medicinal preparations for the treatment of cancer; vaccines for human use

Classification Information


Class [042]
Computer & Software Services & Scientific Services


Development of nanotechnology-based pharmaceutical preparations for cancer delivery platforms; research and development of pharmaceuticals for the treatment of cancer; research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines

Class [005]
Pharmaceutical Products


Pharmaceutical and medicinal preparations for the treatment of cancer; vaccines for human use

Mark Details


Serial Number

No 97600809

Mark Type

No Service Mark

Attorney Docket Number

No 348347-NEW

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
19th Dec 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
24th Oct 2023PUBLISHED FOR OPPOSITION
24th Oct 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04th Oct 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
16th Sep 2023APPROVED FOR PUB - PRINCIPAL REGISTER
15th Sep 2023TEAS/EMAIL CORRESPONDENCE ENTERED
14th Sep 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
14th Sep 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
30th Jun 2023ASSIGNED TO EXAMINER
30th Jun 2023NON-FINAL ACTION WRITTEN